PharmAbcine Inc
KOSDAQ:208340
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
PharmAbcine Inc
KOSDAQ:208340
|
KR |
|
Venus Metals Corporation Ltd
ASX:VMC
|
AU |
|
Tatva Chintan Pharma Chem Ltd
BSE:543321
|
IN |
|
D
|
Dae Hwa Pharm Co Ltd
KOSDAQ:067080
|
KR |
|
Kobe Steel Ltd
OTC:KBSTF
|
JP |
|
K
|
Klimat X Developments Inc
XTSX:KLX
|
CA |
|
Logista Integral SA
F:5CI
|
ES |
|
I
|
InnoGene Co Ltd
KOSDAQ:344860
|
KR |
|
W
|
WinHiTech Co Ltd
KOSDAQ:192390
|
KR |
|
D
|
DataLogic International Inc
OTC:DLGI
|
US |
|
T
|
Texas Gulf Energy Inc
OTC:TXGE
|
US |
|
H
|
Hemisphere Energy Corp
XMUN:N4Q1
|
CA |
|
Duketon Mining Ltd
F:DKN
|
AU |
|
R
|
Rorze Systems Corp
KOSDAQ:071280
|
KR |
|
T
|
Taiga Building Products Ltd
OTC:TGAFF
|
CA |
|
mPay SA
F:8NJ
|
PL |
|
N
|
Nousbo Co Ltd
KOSDAQ:332290
|
KR |
|
Ethema Health Corp
OTC:GRST
|
US |
Bankruptcy Probability
PharmAbcine Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
PharmAbcine Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
P
|
PharmAbcine Inc
KOSDAQ:208340
|
9.2B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
504.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
237.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
193.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
132.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
79.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
PharmAbcine Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, PharmAbcine Inc has total debt of 700.2m KRW. This includes both short-term (0 KRW) and long-term (700.2m KRW) debt.
You can find a full breakdown on its Balance Sheet.